Krystal Biotech (KRYS) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Krystal Biotech (KRYS) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Krystal Biotech

· KRYS

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

9.917 B

-0.75%

General

Market Cap: $9.92B
Enterprise Value: $9.38B
Shares Outstanding: 29,480,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 93.34%
Operating Margin: 44.93%
Net Profit Margin: 54.82%
FCF Margin: 58.52%
ROA: 16.09%
ROE: 19.34%
ROIC: 14.39%
Current Ratio: 8.32
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: 40.67
PEG: 1.01
P/S: 22.26
P/FCF: 38.03
P/B: 7.21
EV/EBITDA: 42.96

Growth

Rev 1Y: 33.94%

Income Statement (TTM)

Revenue: $440.48M
Gross Margin: 93.34%
Operating Expenses: $213.23M
Operating Income: $197.92M
Net Profit: $241.47M

Balance Sheet

Rev 1Y Fwd Est

30.32%

Rev 3Y (CAGR)

—

Rev 5Y (CAGR)

—

Rev 10Y (CAGR)

—

EPS 1Y

128.00%

EPS 1Y Fwd Est

11.22%

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $427.74M
Working Capital: $932.25M
Total Assets: $1.5B
Net Debt: -$418.89M
Total Liabilities: $141.52M
Total Equity: $1.36B

Cash Flow Statement (TTM)

Cash Flow from Operations: $272.34M
Cash Flow from Investing: -$218.29M
Cash Flow from Financing: $23.97M
Free Cash Flow: $257.78M
Capital Expenditures: $14.56M